Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
By R. Djukanović, S. Wilson, M. Kraft, N. Jarjour, Mark D Steel, K. Chung, W. Bao, A. Fowler-Taylor, J. Matthews, W. Busse and 2 more. American Journal of Respiratory and Critical Care Medicine, 2004
645 citations recorded by the source corpus.
Subfields: Immunology and Allergy, Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/c785e791a018d64ea11ee290276a7e9ca8d3535e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- The role of the mast cell in the pathophysiology of asthma. (2006, result): “This is supported to some extent by the observation that anti-IgE therapy markedly reduces both airway inflammation and mast cell activation, as manifest by reduced IL-4 expression.(38) However, anti-IgE therapy has a minimal effect on BHR, suggesting that monomeric IgE-dependent activation of mast ”